losartan has been researched along with transferrin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Fernández, A; Hortal, L; Lorenzo, M; Losada, A; Palop, L; Plaza, C; RodrÃguez, JC; Vega, N | 1 |
Fujita, H; Hosoba, M; Ito, S; Kakei, M; Miura, T; Morii, T; Narita, T; Sasaki, H | 1 |
Lamptey, RNL; Singh, J; Sun, C | 1 |
1 trial(s) available for losartan and transferrin
Article | Year |
---|---|
Losartan versus ramipril in the treatment of postrenal transplant erythrocytosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Erythrocyte Count; Erythropoietin; Hematocrit; Humans; Kidney Transplantation; Losartan; Polycythemia; Postoperative Complications; Ramipril; Reticulocyte Count; Transferrin | 1998 |
2 other study(ies) available for losartan and transferrin
Article | Year |
---|---|
Low dose of losartan decreased urinary excretions of IgG, transferrin, and ceruloplasmin without reducing albuminuria in normoalbuminuric type 2 diabetic patients.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Ceruloplasmin; Diabetes Mellitus, Type 2; Female; Humans; Immunoglobulin G; Losartan; Male; Middle Aged; Renin; Transferrin | 2008 |
Brain-targeted delivery of losartan through functionalized liposomal nanoparticles for management of neurogenic hypertension.
Topics: Animals; Brain; Hypertension; Liposomes; Losartan; Nanoparticles; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Transferrin | 2023 |